These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 14676629)

  • 41. Inhibition of myeloid dendritic cell accessory cell function and induction of T cell anergy by alcohol correlates with decreased IL-12 production.
    Mandrekar P; Catalano D; Dolganiuc A; Kodys K; Szabo G
    J Immunol; 2004 Sep; 173(5):3398-407. PubMed ID: 15322204
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Notch signaling regulates the development of a novel type of Thy1-expressing dendritic cell in the thymus.
    Ishifune C; Maekawa Y; Nishida J; Kitamura A; Tanigaki K; Yagita H; Yasutomo K
    Eur J Immunol; 2011 May; 41(5):1309-20. PubMed ID: 21469122
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Cognate interactions between memory T cells and tumor antigen-presenting dendritic cells from bone marrow of breast cancer patients: bidirectional cell stimulation, survival and antitumor activity in vivo.
    Bai L; Beckhove P; Feuerer M; Umansky V; Choi C; Solomayer FS; Diel IJ; Schirrmacher V
    Int J Cancer; 2003 Jan; 103(1):73-83. PubMed ID: 12455056
    [TBL] [Abstract][Full Text] [Related]  

  • 44. CD3-mediated T cell activation is inhibited by anti-CD44 monoclonal antibodies directed to the hyaluronan-binding region.
    Sugiyama K; Komada Y; Deguchi T; Zhang XL; Azuma E; Ido M; Yamamoto H; Sakurai M
    Immunol Invest; 1999; 28(2-3):185-200. PubMed ID: 10484683
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Cyclophosphamide induces bone marrow to yield higher numbers of precursor dendritic cells in vitro capable of functional antigen presentation to T cells in vivo.
    Salem ML; El-Naggar SA; Cole DJ
    Cell Immunol; 2010; 261(2):134-43. PubMed ID: 20036354
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Dendritic cell longevity and T cell persistence is controlled by CD154-CD40 interactions.
    Miga AJ; Masters SR; Durell BG; Gonzalez M; Jenkins MK; Maliszewski C; Kikutani H; Wade WF; Noelle RJ
    Eur J Immunol; 2001 Mar; 31(3):959-65. PubMed ID: 11241301
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Murine bone marrow mesenchymal stem cells cause mature dendritic cells to promote T-cell tolerance.
    Wang Q; Sun B; Wang D; Ji Y; Kong Q; Wang G; Wang J; Zhao W; Jin L; Li H
    Scand J Immunol; 2008 Dec; 68(6):607-15. PubMed ID: 18959624
    [TBL] [Abstract][Full Text] [Related]  

  • 48. FcRγ-chain ITAM signaling is critically required for cross-presentation of soluble antibody-antigen complexes by dendritic cells.
    Boross P; van Montfoort N; Stapels DA; van der Poel CE; Bertens C; Meeldijk J; Jansen JH; Verbeek JS; Ossendorp F; Wubbolts R; Leusen JH
    J Immunol; 2014 Dec; 193(11):5506-14. PubMed ID: 25355925
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Induction of dendritic cell costimulator molecule expression is suppressed by T cells in the absence of antigen-specific signalling: role of cluster formation, CD40 and HLA-class II for dendritic cell activation.
    McLellan AD; Heiser A; Hart DN
    Immunology; 1999 Oct; 98(2):171-80. PubMed ID: 10540215
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Contrasting impacts of immunosuppressive agents (rapamycin, FK506, cyclosporin A, and dexamethasone) on bidirectional dendritic cell-T cell interaction during antigen presentation.
    Matsue H; Yang C; Matsue K; Edelbaum D; Mummert M; Takashima A
    J Immunol; 2002 Oct; 169(7):3555-64. PubMed ID: 12244145
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Tumor-induced interleukin 10 suppresses the ability of splenic dendritic cells to stimulate CD4 and CD8 T-cell responses.
    Yang AS; Lattime EC
    Cancer Res; 2003 May; 63(9):2150-7. PubMed ID: 12727833
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Chemotherapeutic agents in noncytotoxic concentrations increase antigen presentation by dendritic cells via an IL-12-dependent mechanism.
    Shurin GV; Tourkova IL; Kaneno R; Shurin MR
    J Immunol; 2009 Jul; 183(1):137-44. PubMed ID: 19535620
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Role of bone marrow-derived CD11c
    Wang H; Kwak D; Fassett J; Liu X; Yao W; Weng X; Xu X; Xu Y; Bache RJ; Mueller DL; Chen Y
    Basic Res Cardiol; 2017 May; 112(3):25. PubMed ID: 28349258
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Dexamethasone inhibits the antigen presentation of dendritic cells in MHC class II pathway.
    Pan J; Ju D; Wang Q; Zhang M; Xia D; Zhang L; Yu H; Cao X
    Immunol Lett; 2001 Apr; 76(3):153-61. PubMed ID: 11306142
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Retrovirally transduced bone marrow-derived dendritic cells require CD4+ T cell help to elicit protective and therapeutic antitumor immunity.
    De Veerman M; Heirman C; Van Meirvenne S; Devos S; Corthals J; Moser M; Thielemans K
    J Immunol; 1999 Jan; 162(1):144-51. PubMed ID: 9886380
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Enhanced activation of human T cells via avipox vector-mediated hyperexpression of a triad of costimulatory molecules in human dendritic cells.
    Zhu M; Terasawa H; Gulley J; Panicali D; Arlen P; Schlom J; Tsang KY
    Cancer Res; 2001 May; 61(9):3725-34. PubMed ID: 11325845
    [TBL] [Abstract][Full Text] [Related]  

  • 57. T cell-dependent maturation of dendritic cells in response to bacterial superantigens.
    Muraille E; De Trez C; Pajak B; Brait M; Urbain J; Leo O
    J Immunol; 2002 May; 168(9):4352-60. PubMed ID: 11970977
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Sequential delivery of maturation stimuli increases human dendritic cell IL-12 production and enhances tumor antigen-specific immunogenicity.
    Kalady MF; Onaitis MW; Emani S; Abdel-Wahab Z; Tyler DS; Pruitt SK
    J Surg Res; 2004 Jan; 116(1):24-31. PubMed ID: 14732346
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Characterization of CD44-mediated hyaluronan binding by renal tubular epithelial cells.
    Oertli B; Fan X; Wüthrich RP
    Nephrol Dial Transplant; 1998 Feb; 13(2):271-8. PubMed ID: 9509434
    [TBL] [Abstract][Full Text] [Related]  

  • 60. TLR7 triggering with polyuridylic acid promotes cross-presentation in CD8α+ conventional dendritic cells by enhancing antigen preservation and MHC class I antigen permanence on the dendritic cell surface.
    Crespo MI; Zacca ER; Núñez NG; Ranocchia RP; Maccioni M; Maletto BA; Pistoresi-Palencia MC; Morón G
    J Immunol; 2013 Feb; 190(3):948-60. PubMed ID: 23284054
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.